Novartis replaces top scientists at Avexis after drug data manipulated

Novartis AG said on Wednesday it replaced the two top research and development executives at its Avexis unit after some data was manipulated from early testing of a gene therapy for infants that costs more than $2 million.


Source: Reuters Health

Be the first to comment

Leave a Reply

Your email address will not be published.


*